Remove the Kyleena Immediately and Replace if Contraception is Desired
A Kyleena IUD that has been in place for 7-8 years is beyond its FDA-approved 5-year lifespan and must be removed, as it no longer provides reliable contraceptive protection and the breakthrough bleeding is likely related to device expiration. 1
Critical Issue: Device Has Exceeded Approved Duration
The FDA-approved duration for Kyleena is 5 years maximum 1. At 7-8 years:
- Contraceptive efficacy is no longer guaranteed - the levonorgestrel reservoir is depleted
- The device is functioning as an expired foreign body
- Breakthrough bleeding at this timepoint signals hormonal depletion rather than a treatable side effect
Immediate Management Steps
1. Remove the Device Promptly
- Schedule removal as soon as feasible
- The patient has no contraceptive protection and should use backup contraception (condoms, spermicide) until removal and replacement 1
- Rule out pregnancy before removal if sexually active
2. Evaluate for Underlying Pathology
Before attributing bleeding solely to the expired device, consider:
- Pregnancy (ectopic or intrauterine)
- Structural causes: polyps, fibroids, adenomyosis
- Endometrial pathology: hyperplasia (especially given prolonged progestin exposure followed by declining levels)
- STIs or cervicitis
- Thyroid disorders or coagulopathy 2
Perform pelvic exam, pregnancy test, and consider transvaginal ultrasound if clinically indicated based on bleeding severity or other symptoms.
3. Counsel on Replacement Options
If the patient desires continued contraception:
- Same-day replacement with new Kyleena or alternative LNG-IUS can be performed at removal visit
- Discuss that a new device will cause initial irregular bleeding (first 3-6 months), but this is expected and different from the current situation 1
- If she experienced amenorrhea with the previous device before it expired, she has a 40-50% chance of achieving amenorrhea again with a new device 3, 4
Why Standard Bleeding Management Does NOT Apply Here
The 2024 CDC guidelines for managing LNG-IUD breakthrough bleeding 2 note "No interventions identified" for LNG-IUD users experiencing bleeding irregularities. However, these recommendations apply to:
- Devices within their approved lifespan
- Early adaptation bleeding (first 6 months)
- Ongoing but stable bleeding patterns
These guidelines do not address expired devices. Research on treatments like NSAIDs, tranexamic acid, or tamoxifen 5, 6 evaluated bleeding in the first 90 days after insertion or during active device use - not expired devices.
Common Pitfall to Avoid
Do not attempt to medically manage the bleeding while leaving an expired device in place. This approach:
- Fails to address the root cause (depleted hormone reservoir)
- Leaves the patient without contraceptive protection
- Delays diagnosis of potential underlying pathology
- May mask symptoms of serious conditions (endometrial hyperplasia, pregnancy)
Clinical Reasoning
An expired LNG-IUS transitions from a therapeutic device to a potential liability. The levonorgestrel release rate declines significantly after 5 years, eliminating both contraceptive efficacy and the endometrial suppression that prevents bleeding 3. The breakthrough bleeding represents return of normal menstrual patterns or potentially pathologic bleeding that was previously suppressed.
The only appropriate management is device removal with evaluation for pathology and discussion of replacement options 1.